{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:56:23Z","timestamp":1746320183149,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NO.81701701"],"award-info":[{"award-number":["NO.81701701"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["NO.2016A030310143"],"award-info":[{"award-number":["NO.2016A030310143"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Department of Finance of Guangdong Province","award":["No.20160904"],"award-info":[{"award-number":["No.20160904"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Post-transplant lymphoproliferative disorders (PTLDs) represent a spectrum of heterogenetic lymphoid proliferations. PTLD is a serious complication that affects the long-term survival of kidney transplant patients. Imaging examination is an important method for detecting and diagnosing PTLD. Contrast-enhanced ultrasonography (CEUS) and CEUS-guided biopsy are important modalities for tumor detection and diagnosis. In this case, we describe a 69\u2009years old man in whom a native kidney PTLD was confirmed by CEUS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 69-year-old male patient who had a kidney transplant 1\u00a0year earlier presented with 3\u00a0months of progressive myasthenia of both lower limbs associated with amyotrophy and weight loss. Although positron emission tomography\/computed tomography (PET-CT) showed a high metabolic lesion in the untransplanted kidney, abdominal contrast enhanced computed tomography cannot detect the lesion in the atrophic left kidney. The above examinations showed that the transplanted kidney was normal. CEUS can detect a homogeneously enhanced lesion in the same location as PET-CT. Subsequently, a biopsy was performed under CEUS guidance, and the final pathological diagnosis was diffuse large B-cell lymphoma. The patient then received the R-CHOP treatment. Unfortunately, pulmonary thromboembolism occurred 2\u00a0weeks later, and the patient\u2019s condition was not alleviated through active treatment. Finally, the patient\u2019s family gave up treatment, and the patient was discharged.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The case suggested that CEUS was a valuable imaging method for patient with renal transplantation to detect and diagnose of PTLD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-019-6355-0","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T16:03:17Z","timestamp":1574352197000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Application of contrast-enhanced ultrasonography in the diagnosis of post-kidney transplant lymphoproliferative disorder in native kidney- a case report"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0685-2311","authenticated-orcid":false,"given":"Jian-Chao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Xia","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Juan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang-Yang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Yan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-de","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9485-583X","authenticated-orcid":false,"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,21]]},"reference":[{"issue":"9","key":"6355_CR1","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1097\/01.tp.0000179639.98338.39","volume":"80","author":"S Caillard","year":"2005","unstructured":"Caillard S, Dharnidharka V, Agodoa L, Bohen E, Abbott K. Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation. 2005;80(9):1233\u201343.","journal-title":"Transplantation"},{"issue":"2","key":"6355_CR2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","volume":"4","author":"G Opelz","year":"2004","unstructured":"Opelz G, D\u00f6hler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant. 2004;4(2):222\u201330.","journal-title":"Am J Transplant"},{"issue":"2","key":"6355_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11060-015-1903-1","volume":"125","author":"DT Ginat","year":"2015","unstructured":"Ginat DT, Purakal A, Pytel P. Susceptibility-weighted imaging and diffusion-weighted imaging findings in central nervous system monomorphic B cell post-transplant lymphoproliferative disorder before and after treatment and comparison with primary B cell central nervous system lymphoma. J Neuro-Oncol. 2015;125(2):297\u2013305.","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"6355_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1148\/radiology.213.1.r99oc2173","volume":"213","author":"PJ Pickhardt","year":"1999","unstructured":"Pickhardt PJ, Siegel MJ. Posttransplantation lymphoproliferative disorder of the abdomen: CT evaluation in 51 patients. Radiology. 1999;213(1):73\u20138.","journal-title":"Radiology"},{"key":"6355_CR5","first-page":"64","volume":"4","author":"JB Abu","year":"2017","unstructured":"Abu JB, Leonard AC, Sharma Y, Katipally S, Shields AR, Alloway RR, Woodle ES, Thakar CV. Contrast-induced nephropathy in renal transplant recipients: a single center experience. Front Med (Lausanne). 2017;4:64.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"6355_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.11152\/mu.2013.2066.172.fsum","volume":"17","author":"Z Sparchez","year":"2015","unstructured":"Sparchez Z, Radu P, Sparchez M, Crisan N, Kacso G, Petrut B. Contrast enhanced ultrasound of renal masses. A reappraisal of EFSUMB recommendations and possible emerging applications. Med Ultrason. 2015;17(2):219\u201326.","journal-title":"Med Ultrason"},{"issue":"1","key":"6355_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1148\/radiol.2017161604","volume":"285","author":"BX Liu","year":"2017","unstructured":"Liu BX, Huang GL, Xie XH, Zhuang BW, Xie XY, Lu MD. Contrast-enhanced US-assisted percutaneous nephrostomy: a technique to increase success rate for patients with nondilated renal collecting system. Radiology. 2017;285(1):293\u2013301.","journal-title":"Radiology"},{"issue":"1","key":"6355_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12882-017-0681-8","volume":"18","author":"EH Chang","year":"2017","unstructured":"Chang EH, Chong WK, Kasoji SK, Fielding JR, Altun E, Mullin LB, Kim JI, Fine JP, Dayton PA, Rathmell WK. Diagnostic accuracy of contrast-enhanced ultrasound for characterization of kidney lesions in patients with and without chronic kidney disease. BMC Nephrol. 2017;18(1):266.","journal-title":"BMC Nephrol"},{"key":"6355_CR9","doi-asserted-by":"crossref","unstructured":"Stock K, Kubler H, Maurer T, Slotta-Huspenina J, Holzapfel K. CEUS-diagnosis of solid renal tumors. Der Radiologe. 2018;58(6):553\u201362.","DOI":"10.1007\/s00117-018-0392-6"},{"key":"6355_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ijscr.2017.07.003","volume":"38","author":"TD Schultz","year":"2017","unstructured":"Schultz TD, Zepeda N, Moore RB. Post-transplant lymphoproliferative disorder and management of residual mass post chemotherapy: case report. Int J Surg Case Rep. 2017;38:115\u20138.","journal-title":"Int J Surg Case Rep"},{"issue":"2","key":"6355_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.14366\/usg.14050","volume":"34","author":"M Lee","year":"2015","unstructured":"Lee M, Kim SK, Chung YE, Choi JY, Park MS, Lim JS, Kim MJ, Kim H. Necrotic lymphoma in a patient with post-transplantation lymphoproliferative disorder: ultrasonography and CT findings with pathologic correlation. Ultrasonography. 2015;34(2):148\u201352.","journal-title":"Ultrasonography"},{"issue":"4","key":"6355_CR12","first-page":"942","volume":"28","author":"A Chandra","year":"2017","unstructured":"Chandra A, Kaul A, Aggarwal V, Srivastava D. Native kidney posttransplant lymphoproliferative disorder in a renal transplant recipient. Saudi J Kidney Dis Transpl. 2017;28(4):942\u20134.","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"2","key":"6355_CR13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ejrad.2007.01.027","volume":"63","author":"J Ferda","year":"2007","unstructured":"Ferda J, Hora M, Hes O, Reischig T, Kreuzberg B, Mirka H, Ferdova E, Ohlidalova K, Baxa J, Urge T. Computed tomography of renal cell carcinoma in patients with terminal renal impairment. Eur J Radiol. 2007;63(2):295\u2013301.","journal-title":"Eur J Radiol"},{"issue":"5","key":"6355_CR14","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.ejrad.2014.12.027","volume":"84","author":"C Trenker","year":"2015","unstructured":"Trenker C, Neesse A, Gorg C. Sonographic patterns of renal lymphoma in B-mode imaging and in contrast-enhanced ultrasound (CEUS)--a retrospective evaluation. Eur J Radiol. 2015;84(5):807\u201310.","journal-title":"Eur J Radiol"},{"issue":"4","key":"6355_CR15","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.2214\/AJR.07.3546","volume":"191","author":"E Quaia","year":"2008","unstructured":"Quaia E, Bertolotto M, Cioffi V, Rossi A, Baratella E, Pizzolato R, Cov MA. Comparison of contrast-enhanced sonography with unenhanced sonography and contrast-enhanced CT in the diagnosis of malignancy in complex cystic renal masses. AJR Am J Roentgenol. 2008;191(4):1239\u201349.","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"6355_CR16","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1148\/radiology.207.3.9609893","volume":"207","author":"DH Sheafor","year":"1998","unstructured":"Sheafor DH, Paulson EK, Simmons CM, DeLong DM, Nelson RC. Abdominal percutaneous interventional procedures: comparison of CT and US guidance. Radiology. 1998;207(3):705\u201310.","journal-title":"Radiology"},{"issue":"6","key":"6355_CR17","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.21037\/jgo.2017.08.17","volume":"8","author":"S Partovi","year":"2017","unstructured":"Partovi S, Lu Z, Kessner R, Yu A, Ahmed Y, Patel IJ, Nakamoto DA, Azar N. Contrast enhanced ultrasound guided biopsies of liver lesions not visualized on standard B-mode ultrasound-preliminary experience. J Gastrointest Oncol. 2017;8(6):1056\u201364.","journal-title":"J Gastrointest Oncol"},{"issue":"6","key":"6355_CR18","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1002\/jum.14498","volume":"37","author":"CP Nolsoe","year":"2018","unstructured":"Nolsoe CP, Nolsoe AB, Klubien J, Pommergaard HC, Rosenberg J, Meloni MF, Lorentzen T. Use of ultrasound contrast agents in relation to percutaneous interventional procedures: a systematic review and pictorial essay. J Ultrasound Med. 2018;37(6):1305\u201324.","journal-title":"J Ultrasound Med"},{"issue":"4","key":"6355_CR19","first-page":"456","volume":"17","author":"Z Sparchez","year":"2015","unstructured":"Sparchez Z, Radu P, Kacso G, Sparchez M, Zaharia T, Al HN. Prospective comparison between real time contrast enhanced and conventional ultrasound guidance in percutaneous biopsies of liver tumors. Med Ultrason. 2015;17(4):456\u201363.","journal-title":"Med Ultrason"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6355-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-6355-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6355-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T01:49:07Z","timestamp":1605836947000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-6355-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,21]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6355"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-6355-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2019,11,21]]},"assertion":[{"value":"2 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient provided written informed consent to publish this report and associated images. We have de-identified demographic information and other specific information of the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Our manuscript has been read and approved by all authors and there are no any financial or other interests in the subject matter of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1135"}}